The Use and Potential of Serum Tumour Markers, New and Old
- 1 July 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 38 (1) , 9-18
- https://doi.org/10.2165/00003495-198938010-00002
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomyEuropean Journal of Cancer and Clinical Oncology, 1987
- Follow-up of colorectal cancer resected for cureDiseases of the Colon & Rectum, 1987
- An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- CEA-Directed Second-look Surgery in the Asymptomatic Patient after Primary Resection of Colorectal CarcinomaAnnals of Surgery, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancerJAMA, 1981
- Detection of Prostatic Cancer by Solid-Phase Radioimmunoassay of Serum Prostatic Acid PhosphataseNew England Journal of Medicine, 1977
- CEA levels in patients with colorectal polypsCancer, 1975